---
title: "纳斯达克深科技指数收跌约 2.3%，表现逊色于美国三大股指。成分股中，Immuneering 跌 43.22%，CorMedix 跌 32.77%，Sionna Therapeutics 跌 15.3"
description: "纳斯达克深科技指数收跌约 2.3%，表现逊色于美国三大股指。成分股中，Immuneering 跌 43.22%，CorMedix 跌 32.77%，Sionna Therapeutics 跌 15.32%，Absci 跌 14.43%，Vanda Pharmaceuticals 跌 14.05%。Xeris Pharmaceuticals 涨 12.62%，Erasca 涨 12.77%，Arde"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/271985555.md"
published_at: "2026-01-08T21:25:51.000Z"
---

# 纳斯达克深科技指数收跌约 2.3%，表现逊色于美国三大股指。成分股中，Immuneering 跌 43.22%，CorMedix 跌 32.77%，Sionna Therapeutics 跌 15.3

> 纳斯达克深科技指数收跌约 2.3%，表现逊色于美国三大股指。成分股中，Immuneering 跌 43.22%，CorMedix 跌 32.77%，Sionna Therapeutics 跌 15.32%，Absci 跌 14.43%，Vanda Pharmaceuticals 跌 14.05%。Xeris Pharmaceuticals 涨 12.62%，Erasca 涨 12.77%，Ardelyx 涨 19.90%，Enliven Therapeutics 涨 50.36%。

纳斯达克深科技指数收跌约 2.3%，表现逊色于美国三大股指。 成分股中，Immuneering 跌 43.22%，CorMedix 跌 32.77%，Sionna Therapeutics 跌 15.32%，Absci 跌 14.43%，Vanda Pharmaceuticals 跌 14.05%。 Xeris Pharmaceuticals 则涨 12.62%，Erasca 涨 12.77%，Ardelyx 涨 19.90%，Enliven Therapeutics 涨 50.36%。

### Related Stocks

- [ERAS.US - Erasca](https://longbridge.com/zh-CN/quote/ERAS.US.md)
- [ELVN.US - Enliven Therapeutics](https://longbridge.com/zh-CN/quote/ELVN.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Enliven Therapeutics Chief Scientific Officer Joseph P. Lyssikatos Reports Disposal of Common Shares | Joseph P. Lyssikatos, Chief Scientific Officer of Enliven Therapeutics Inc., has reported the disposal of common shares  | [Link](https://longbridge.com/zh-CN/news/275523266.md) |
| Erasca Touts Early ERAS-0015 Responses, Potency Edge in Guggenheim Fireside Chat | Erasca (NASDAQ:ERAS) executives discussed early clinical signals and their RAS-focused pipeline during a Guggenheim fire | [Link](https://longbridge.com/zh-CN/news/275937678.md) |
| Smartcraft ASA - Smartcraft Group AB (Publ) Has Been Approved For Listing On Nasdaq Stockholm | Smartcraft ASA :SMARTCRAFT ASA - SMARTCRAFT GROUP AB (PUBL) HAS BEEN APPROVED FOR LISTING ON NASDAQ STOCKHOLM | [Link](https://longbridge.com/zh-CN/news/275783474.md) |
| Medexus Pharmaceuticals reports Q3 results | Medexus Pharmaceuticals reports Q3 results | [Link](https://longbridge.com/zh-CN/news/275670725.md) |
| Apellis Pharmaceuticals, Inc. $APLS Shares Sold by Savant Capital LLC | Savant Capital LLC reduced its stake in Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) by 50.7% in Q3, now holding 48,886  | [Link](https://longbridge.com/zh-CN/news/275591859.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。